Skip to content
← Full study record

NCT01682083 · BASELINE

Baseline characteristics

Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). · Source last updated 2026-04-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      438
    2. group Id
      BG001
      value
      432
    3. group Id
      BG002
      value
      870
    units
    Participants
groups
  1. description
    Subjects received dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) orally for 12 months.
    id
    BG000
    title
    Dabrafenib and Trametinib Combination Therapy
  2. description
    Subjects received matching placebos orally for 12 months
    id
    BG001
    title
    Dabrafenib and Trametinib Placebos
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          14.17
          value
          50.4
        2. group Id
          BG001
          spread
          13.14
          value
          50.5
        3. group Id
          BG002
          spread
          13.66
          value
          50.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          195
        2. group Id
          BG001
          value
          193
        3. group Id
          BG002
          value
          388
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          243
        2. group Id
          BG001
          value
          239
        3. group Id
          BG002
          value
          482
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          432
        2. group Id
          BG001
          value
          427
        3. group Id
          BG002
          value
          859
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          5
        3. group Id
          BG002
          value
          11
      title
      Asian
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      438
    2. group Id
      BG001
      value
      432
    3. group Id
      BG002
      value
      870
    units
    Participants
groups
  1. description
    Subjects received dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) orally for 12 months.
    id
    BG000
    title
    Dabrafenib and Trametinib Combination Therapy
  2. description
    Subjects received matching placebos orally for 12 months
    id
    BG001
    title
    Dabrafenib and Trametinib Placebos
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          14.17
          value
          50.4
        2. group Id
          BG001
          spread
          13.14
          value
          50.5
        3. group Id
          BG002
          spread
          13.66
          value
          50.4
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          195
        2. group Id
          BG001
          value
          193
        3. group Id
          BG002
          value
          388
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          243
        2. group Id
          BG001
          value
          239
        3. group Id
          BG002
          value
          482
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          432
        2. group Id
          BG001
          value
          427
        3. group Id
          BG002
          value
          859
      title
      White
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          5
        3. group Id
          BG002
          value
          11
      title
      Asian
    param Type
    NUMBER
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice